Pharmacogenomics in oncology - Scientific guideline
HumanScientific guidelines
On Monday, 12 January 2026, between 07:00 and 10:00 CET (Amsterdam time), this website will be unavailable due to scheduled maintenance.
This document examines the impact of pharmacogenomic/pharmacogenetic information on the regulatory process in oncology.
Keywords: Pharmacogenetics, pharmacogenomics, oncology, polymorphisms, metabolism enzymes, receptors